In addition, cisplatin treatment could induce the EMT phenotype and facilitate malignant progression even drug resistance in ovarian carcinoma cells and prostate cancer cells by several transcription factors such as Snail, Slug, and metalloproteinase 9 (Latifi et al., 2011; Liu et al., 2015). Here, SNAI2 is linked to prostate carcinoma.